Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

The new section 103(b) of the patent law: An obvious solution?

Abstract

Given biotechnology's difficulties in obtaining process patents in the past, does section 103(b) offer the best solution?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pub. Law No. 104-41 (Nov. 1, 1995) (to be codified at 35 U.S.C. §103(b)).

  2. U.S.P.Q.2d 1127 (Fed. Cir. 1995).

  3. Appeal No. 92-1225 (Fed. Cir. Dec. 13, 1995).

  4. The Official Gazette notice on this subject is available on the Web at http://www.uspto.gov/web/uspto/og/ ochiai.html.

  5. 763 F.2d 1406,226 U.S.P.Q. 359 (Fed. Cir. 1985).

  6. 383 U.S. 1,148 U.S.P.Q. 459 (1966).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Horn, C., Barlow, S. The new section 103(b) of the patent law: An obvious solution?. Nat Biotechnol 14, 773–774 (1996). https://doi.org/10.1038/nbt0696-773

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0696-773

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing